Regarding the management of cyclic neutropenia, the patient was initially administered granulocyte colony stimulating factor (G-CSF) 2 mcg/kg/24 h in a five-day course before the expected episodes of neutropenia. This evidence concerns the gene CSF3 and neutropenia.